Pancreatic Cancer Research

ResearcherUniversity of UtahActive in the last 2 years

Conan Kinsey

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5614-8627; OpenAlex author ID A5080566114; NIH RePORTER profile ID 15159338. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 0, last author 2)
Trials
1 (principal investigator on 1)
Grants
1
Labs led
1
Collaborators
11
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 trial · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 grant

Papers 4

  1. MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. Last author DOI 10.1084/jem.20221524↗
  2. Therapeutic Targeting of Autophagy in Pancreatic Cancer. Last author DOI 10.1016/j.soc.2021.06.001↗
  3. Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle. Co-author DOI 10.21037/jgo.2018.05.16↗
  4. Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Co-author DOI 10.1016/j.celrep.2014.03.061↗

Trials 1

  1. Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer Principal investigator NCT03825289↗

Grants 1

  1. Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer K08CA230151↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ignacio Garrido‐Laguna · 2 shared papers, 2018–2021 · strength 0.33
  2. Mona Foth · 1 shared paper, 2021 · strength 0.22
  3. Mark R. Silvis · 1 shared paper, 2023 · strength 0.18
  4. Kajsa E. Affolter · 1 shared paper, 2023 · strength 0.18
  5. Martin McMahon · 1 shared paper, 2023 · strength 0.18
  6. Snehal Gajiwala · 1 shared paper, 2018 · strength 0.11
  7. Anna M. Torgeson · 1 shared paper, 2018 · strength 0.11
  8. Shane A. J. Lloyd · 1 shared paper, 2018 · strength 0.11
  9. Hartmut Land · 1 shared paper, 2014 · strength 0.04
  10. Jing Li Huang · 1 shared paper, 2014 · strength 0.04
  11. Aram F. Hezel · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.